Serum antimüllerian hormone in healthy premenopausal women

Christiana M. Shaw, Frank Z. Stanczyk, Brian L. Egleston, L. L. Kahle, Cynthia S. Spittle, Andrew K. Godwin, Louise A. Brinton, Joanne F. Dorgan

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

Antimüllerian hormone (AMH) is extensively studied in ovarian aging and pathology; however, little is known about correlates in healthy premenopausal women. We found that AMH levels are strongly inversely associated with age and differed significantly between oral contraceptive pill users and nonusers, whereas no significant associations were seen between AMH and other clinical, behavioral, and anthropometric characteristics and laboratory variables, making it an attractive hormone for clinical applications.

Original languageEnglish
Pages (from-to)2718-2721
Number of pages4
JournalFertility and Sterility
Volume95
Issue number8
DOIs
StatePublished - Jun 30 2011

Keywords

  • Müllerian-inhibiting substance (MIS)
  • antimüllerian hormone (AMH)
  • healthy
  • ovary
  • premenopausal

Fingerprint

Dive into the research topics of 'Serum antimüllerian hormone in healthy premenopausal women'. Together they form a unique fingerprint.

Cite this